Recent advances in methods to assess the activity of the kinome [version 1; referees: 3 approved]
Protein and lipid kinases are deregulated in most, if not all, cancers and are among the most valuable therapeutic targets in these diseases. Despite the introduction of dozens of effective kinase inhibitors into clinical practice, the development of drug resistance remains a major barrier to treatm...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2017-06-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/6-1004/v1 |
id |
doaj-9715b0b15a304368b56ad2e1edc401bc |
---|---|
record_format |
Article |
spelling |
doaj-9715b0b15a304368b56ad2e1edc401bc2020-11-25T03:35:34ZengF1000 Research LtdF1000Research2046-14022017-06-01610.12688/f1000research.10962.111816Recent advances in methods to assess the activity of the kinome [version 1; referees: 3 approved]Maria Radu0Jonathan Chernoff1Cancer Biology Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111-2497, USACancer Biology Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111-2497, USAProtein and lipid kinases are deregulated in most, if not all, cancers and are among the most valuable therapeutic targets in these diseases. Despite the introduction of dozens of effective kinase inhibitors into clinical practice, the development of drug resistance remains a major barrier to treatment because of adaption of cellular signaling pathways to bypass targeted kinases. So that the basal and adaptive responses of kinases in cancer can be better understood, new methods have emerged that allow simultaneous and unbiased measurement of the activation state of a substantial fraction of the entire kinome. Here, we discuss such kinome-profiling methodologies, emphasizing the relative strengths and weaknesses of each approach.https://f1000research.com/articles/6-1004/v1BiocatalysisCancer TherapeuticsCell SignalingDrug Discovery & DesignMedical GeneticsProtein Chemistry & Proteomics |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maria Radu Jonathan Chernoff |
spellingShingle |
Maria Radu Jonathan Chernoff Recent advances in methods to assess the activity of the kinome [version 1; referees: 3 approved] F1000Research Biocatalysis Cancer Therapeutics Cell Signaling Drug Discovery & Design Medical Genetics Protein Chemistry & Proteomics |
author_facet |
Maria Radu Jonathan Chernoff |
author_sort |
Maria Radu |
title |
Recent advances in methods to assess the activity of the kinome [version 1; referees: 3 approved] |
title_short |
Recent advances in methods to assess the activity of the kinome [version 1; referees: 3 approved] |
title_full |
Recent advances in methods to assess the activity of the kinome [version 1; referees: 3 approved] |
title_fullStr |
Recent advances in methods to assess the activity of the kinome [version 1; referees: 3 approved] |
title_full_unstemmed |
Recent advances in methods to assess the activity of the kinome [version 1; referees: 3 approved] |
title_sort |
recent advances in methods to assess the activity of the kinome [version 1; referees: 3 approved] |
publisher |
F1000 Research Ltd |
series |
F1000Research |
issn |
2046-1402 |
publishDate |
2017-06-01 |
description |
Protein and lipid kinases are deregulated in most, if not all, cancers and are among the most valuable therapeutic targets in these diseases. Despite the introduction of dozens of effective kinase inhibitors into clinical practice, the development of drug resistance remains a major barrier to treatment because of adaption of cellular signaling pathways to bypass targeted kinases. So that the basal and adaptive responses of kinases in cancer can be better understood, new methods have emerged that allow simultaneous and unbiased measurement of the activation state of a substantial fraction of the entire kinome. Here, we discuss such kinome-profiling methodologies, emphasizing the relative strengths and weaknesses of each approach. |
topic |
Biocatalysis Cancer Therapeutics Cell Signaling Drug Discovery & Design Medical Genetics Protein Chemistry & Proteomics |
url |
https://f1000research.com/articles/6-1004/v1 |
work_keys_str_mv |
AT mariaradu recentadvancesinmethodstoassesstheactivityofthekinomeversion1referees3approved AT jonathanchernoff recentadvancesinmethodstoassesstheactivityofthekinomeversion1referees3approved |
_version_ |
1724553635401039872 |